rs79970751

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001330078.2(NRXN1):​c.3933A>G​(p.Ala1311Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00666 in 1,614,012 control chromosomes in the GnomAD database, including 55 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0049 ( 6 hom., cov: 33)
Exomes 𝑓: 0.0068 ( 49 hom. )

Consequence

NRXN1
NM_001330078.2 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: 0.957

Publications

4 publications found
Variant links:
Genes affected
NRXN1 (HGNC:8008): (neurexin 1) This gene encodes a single-pass type I membrane protein that belongs to the neurexin family. Neurexins are cell-surface receptors that bind neuroligins to form Ca(2+)-dependent neurexin/neuroligin complexes at synapses in the central nervous system. This complex is required for efficient neurotransmission and is involved in the formation of synaptic contacts. Three members of this gene family have been studied in detail and are estimated to generate over 3,000 variants through the use of two alternative promoters (alpha and beta) and extensive alternative splicing in each family member. Recently, a third promoter (gamma) was identified for this gene in the 3' region. Mutations in this gene are associated with Pitt-Hopkins-like syndrome-2 and may contribute to susceptibility to schizophrenia. [provided by RefSeq, Aug 2016]
NRXN1 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • chromosome 2p16.3 deletion syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • Pitt-Hopkins-like syndrome 2
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
  • autism
    Inheritance: AD Classification: MODERATE Submitted by: G2P
  • schizophrenia
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 2-50053466-T-C is Benign according to our data. Variant chr2-50053466-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 93602.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.957 with no splicing effect.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00493 (751/152290) while in subpopulation AMR AF = 0.00883 (135/15294). AF 95% confidence interval is 0.00761. There are 6 homozygotes in GnomAd4. There are 349 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 6 AR,AD,Unknown gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001330078.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NRXN1
NM_001330078.2
MANE Select
c.3933A>Gp.Ala1311Ala
synonymous
Exon 21 of 23NP_001317007.1Q9ULB1-5
NRXN1
NM_001135659.3
c.4053A>Gp.Ala1351Ala
synonymous
Exon 22 of 24NP_001129131.1Q9ULB1-3
NRXN1
NM_001330093.2
c.3930A>Gp.Ala1310Ala
synonymous
Exon 21 of 23NP_001317022.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NRXN1
ENST00000401669.7
TSL:5 MANE Select
c.3933A>Gp.Ala1311Ala
synonymous
Exon 21 of 23ENSP00000385017.2Q9ULB1-5
NRXN1
ENST00000404971.5
TSL:1
c.4053A>Gp.Ala1351Ala
synonymous
Exon 22 of 24ENSP00000385142.1Q9ULB1-3
NRXN1
ENST00000625672.2
TSL:1
c.3909A>Gp.Ala1303Ala
synonymous
Exon 19 of 21ENSP00000485887.1Q9ULB1-2

Frequencies

GnomAD3 genomes
AF:
0.00494
AC:
751
AN:
152172
Hom.:
6
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00154
Gnomad AMI
AF:
0.0274
Gnomad AMR
AF:
0.00884
Gnomad ASJ
AF:
0.00836
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.000847
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00695
Gnomad OTH
AF:
0.00525
GnomAD2 exomes
AF:
0.00400
AC:
1005
AN:
251110
AF XY:
0.00403
show subpopulations
Gnomad AFR exome
AF:
0.00105
Gnomad AMR exome
AF:
0.00324
Gnomad ASJ exome
AF:
0.00764
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000601
Gnomad NFE exome
AF:
0.00642
Gnomad OTH exome
AF:
0.00637
GnomAD4 exome
AF:
0.00684
AC:
9993
AN:
1461722
Hom.:
49
Cov.:
32
AF XY:
0.00665
AC XY:
4839
AN XY:
727154
show subpopulations
African (AFR)
AF:
0.00143
AC:
48
AN:
33468
American (AMR)
AF:
0.00315
AC:
141
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.00696
AC:
182
AN:
26134
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39696
South Asian (SAS)
AF:
0.000765
AC:
66
AN:
86256
European-Finnish (FIN)
AF:
0.000674
AC:
36
AN:
53392
Middle Eastern (MID)
AF:
0.0125
AC:
72
AN:
5768
European-Non Finnish (NFE)
AF:
0.00811
AC:
9022
AN:
1111918
Other (OTH)
AF:
0.00704
AC:
425
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
610
1220
1831
2441
3051
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
358
716
1074
1432
1790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00493
AC:
751
AN:
152290
Hom.:
6
Cov.:
33
AF XY:
0.00469
AC XY:
349
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.00154
AC:
64
AN:
41568
American (AMR)
AF:
0.00883
AC:
135
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00836
AC:
29
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.000621
AC:
3
AN:
4830
European-Finnish (FIN)
AF:
0.000847
AC:
9
AN:
10626
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00695
AC:
473
AN:
68012
Other (OTH)
AF:
0.00520
AC:
11
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
36
72
107
143
179
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00585
Hom.:
2
Bravo
AF:
0.00498
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00753
EpiControl
AF:
0.00747

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not provided (6)
-
-
3
not specified (3)
-
-
2
Pitt-Hopkins-like syndrome 2 (2)
-
-
1
Inborn genetic diseases (1)
-
-
1
NRXN1-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
8.0
DANN
Benign
0.65
PhyloP100
0.96
Mutation Taster
=83/17
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs79970751; hg19: chr2-50280604; API